Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants

By L. Abu-Raddad, H. Chemaitelly, A. Butt. New England Journal of Medicine, 2021

862 citations recorded by the source corpus.

Subfields: Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/f3f2280d1f5ef7ba6c53d4bb70d1a3c9c2d05f63

Citations in the corpus

• Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review (2021, neutral): “Effectiveness against COVID-19 (symptomatic infection) After full immunization, mRNA vaccine effectiveness against disease was 88e100% against Alpha [36e43], 76e100% against Beta/Gamma [37,38,40], 47.3e88% against Delta [38,44e47], and 89e100% when SRAS-CoV-2 strain was not sequenced [40,41,48e53] (”